SPY749.60−0.63%QQQ674.25−0.83%BTC/USD66,888.80−1.97%DIA521.21−0.37%GLD355.70+0.07%TLT79.42+0.05%

Harvard Bioscience Inc

HBIONASDAQ

Trade with Public

$9.39

0.181.9%

Last update: Nov 12, 5:52 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Earnings: Q3 2026 Earnings were released on Tue Nov 10th, before the market open

Conference Call: The most recent conference call started at 8:00 AM, 4 days ago

Click to view the webcast

Harvard Bioscience (HBIO) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Harvard Bioscience (HBIO) stock.

Analyst Consensus — 1 Analysts

1Hold

# Analysts1

Latest Upgrades and Downgrades for Harvard Bioscience Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	StoneX	Bruce D. Jackson	Downgrade	Speculative Buy→Hold	—
—	Benchmark	Bruce D. Jackson	PT Raise	Speculative Buy	$6→$8
—	Benchmark	Bruce D. Jackson	PT Raise	Speculative Buy	$1→$6
—	Benchmark	Bruce D. Jackson	PT Cut	Speculative Buy	$2→$1
—	Benchmark	Bruce D. Jackson	PT Cut	Speculative Buy	$30→$20
—	Benchmark	Bruce Jackson	PT Cut	Speculative Buy	$45→$30
—	Keybanc	Paul Knight	Downgrade	Overweight→Sector Weight	—
—	Benchmark	Bruce Jackson	PT Cut	Speculative Buy	$55→$45

Harvard Bioscience Inc

Harvard Bioscience (HBIO) Stock Price Target 2026

Latest Upgrades and Downgrades for Harvard Bioscience Stock

Harvard Bioscience (HBIO) Stock Price Target 2026

Latest Upgrades and Downgrades for Harvard Bioscience Stock

Analyst Ratings News

PRO
StoneX Downgrades Harvard Bioscience to Hold

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $6

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $0.6

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $2

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $3

People Also Watch

People Also Watch

Analyst Ratings News

PRO
StoneX Downgrades Harvard Bioscience to Hold

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $6

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $0.6

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $2

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $3

Harvard Bioscience Inc

Harvard Bioscience (HBIO) Stock Price Target 2026

Latest Upgrades and Downgrades for Harvard Bioscience Stock

Harvard Bioscience (HBIO) Stock Price Target 2026

Latest Upgrades and Downgrades for Harvard Bioscience Stock

Analyst Ratings News

PROStoneX Downgrades Harvard Bioscience to Hold

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $6

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $0.6

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $2

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $3

People Also Watch

People Also Watch

Analyst Ratings News

PROStoneX Downgrades Harvard Bioscience to Hold

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $6

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $0.6

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $2

PROBenchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $3

PRO
StoneX Downgrades Harvard Bioscience to Hold

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $6

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $0.6

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $2

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $3

PRO
StoneX Downgrades Harvard Bioscience to Hold

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $6

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $0.6

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $2

PRO
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $3